Bioline Rx reported $19.53M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Arca Biopharma USD 486.79M 143.15M Sep/2025
Bio Path USD -7.16M 4.57M Jun/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 83.87M 21.11M Sep/2025